Edwards Lifesciences Debt Current Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 112.03  0.83  0.75%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Debt Current of Edwards Lifesciences Corporation with missing and latest data points interpolated. The current portion of Total Debt, reported if the company operates a classified balance sheet that segments current and non-current liabilities.
Debt Current  10 Years Trend  
Decreasing
Stable
 Debt Current 
      Timeline 

Edwards Lifesciences Debt Current Over Time

2015-12-31  41,800,000 
2016-12-31  41,800,000 
2017-12-31  49,176,471 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  48,039,706
Geometric Mean  34,805,856
Coefficient Of Variation  71.43
Mean Deviation  17,182,843
Median  41,800,000
Standard Deviation  34,312,647
Range  148,900,000
R Value (0.16)
R Squared  0.026727
Significance  0.61
Slope (1,555,800)

Currently Trending

CMRE   
 NYQ 
Purchased over 100 shares of
1 hour ago ago
Traded for 6.24
SKM   
 NYQ 
Purchased over 100 shares of
1 hour ago ago
Traded for 25.77
CHL   
 NYQ 
Purchased over 100 shares of
1 hour ago ago
Traded for 50.17